3.4 Phlebitis: Prevention, Grading & Management
Key Takeaways
- Phlebitis is inflammation of the vein and may be chemical, mechanical, infectious, or mixed—do not assume every red site is only “irritation.”
- Risk rises with larger gauge catheters, poor site choice (areas of flexion), irritating infusates, prolonged dwell, inadequate securement, and breaks in asepsis.
- The INS Phlebitis Scale grades 0-4: Grade 1 is erythema with or without pain, Grade 2 adds pain with erythema and/or edema, Grade 3 adds streak formation and a palpable venous cord, and Grade 4 adds a cord longer than 1 inch plus purulent drainage.
- Prevention rests on device and site selection, dilution and rate strategies for irritants, securement, routine site assessment, and aseptic technique; management is stopping the infusion, removing the catheter when indicated, restarting elsewhere if therapy continues, comfort measures such as a warm compress, and escalating when infection is suspected.
- The 9th edition Infusion Therapy Standards of Practice widened the post-infusion phlebitis window from within 48 hours to 48-96 hours after catheter removal, with reported rates of roughly 1%-23%.
What phlebitis is—and why infusion nurses own it
Phlebitis is inflammation of a vein. In infusion therapy it most often involves peripheral veins used for short peripheral catheters, but similar inflammatory and infectious processes can affect longer peripherals, midlines, and central device tracts or tunnels in different forms. Phlebitis causes pain, interrupts therapy, consumes new insertion attempts, and—when infectious—can progress to suppurative thrombophlebitis or bloodstream infection.
CRNI Domain 1B groups phlebitis with infection prevention strategies because infectious phlebitis is on the continuum of device-related infection, and because many “non-infectious” cases are still prevented by the same habits: right device, right site, right technique, right monitoring.
Mechanisms: chemical, mechanical, infectious
Chemical phlebitis
Caused by the infusate or medication irritating the endothelium. Contributors include:
- Extremes of pH (very acidic or alkaline drugs)
- High osmolarity solutions
- Vesicants/irritants given peripherally when central administration is indicated
- Particulate matter or inadequate filtration when filtration is required
- Concentrated electrolytes (e.g., higher-concentration potassium, some electrolytes) infused too quickly into small veins
Prevention levers: dilute per drug references when appropriate, use recommended final concentrations, control rate, choose a larger vein or more appropriate device (midline/central) for prolonged irritant therapy, and verify compatibility.
Mechanical phlebitis
Caused by physical trauma to the vein wall:
- Catheter too large for the vein (high catheter-to-vein ratio)
- Insertion site over areas of flexion (antecubital fossa for continuous infusions is a classic problem)
- Poor securement allowing in-and-out motion (pistoning)
- Traumatic insertion with multiple attempts
- Catheter material stiffness and patient movement
Prevention levers: smallest gauge that meets therapy needs, avoid flexion sites for continuous infusions when possible, use engineered securement devices, stabilize during patient activity, and limit unnecessary catheter manipulation.
Infectious phlebitis
Caused by microbial invasion of the vein or peri-catheter tissues. May follow breaks in aseptic technique, contaminated solutions, or migration of skin flora. Signs can overlap with chemical/mechanical inflammation early, then progress to purulence, fever, or systemic infection.
Prevention levers: hand hygiene, skin antisepsis with dry time, non-touch of key parts, hub disinfection, intact dressings, and prompt removal of catheters that are no longer needed or that show infectious signs.
Mixed etiology is common—an irritant drug in a poorly secured large catheter at the wrist can produce chemical plus mechanical injury that then becomes secondarily infected.
Grading phlebitis: the INS Phlebitis Scale
Standardized grading improves communication and triggers action before severe injury. The INS Phlebitis Scale is the 0–4 tool published in the Infusion Therapy Standards of Practice, and it is the scale CRNI stems are built around. Learn it as a cumulative ladder—each grade adds findings on top of the grade below it.
| Grade | Clinical criteria (INS Phlebitis Scale) | Usual action |
|---|---|---|
| 0 | No symptoms | Continue routine assessment |
| 1 | Erythema at access site with or without pain | Increase monitoring; address cause (rate, drug, securement) |
| 2 | Pain at access site with erythema and/or edema | Remove catheter; restart elsewhere if therapy continues |
| 3 | Pain with erythema and/or edema plus streak formation plus palpable venous cord | Remove; escalate assessment; document; reconsider device and therapy plan |
| 4 | All Grade 3 findings plus palpable venous cord >1 inch (2.5 cm) plus purulent drainage | Remove; treat as possible infection—cultures, provider notification, source control |
How to read the scale on exam stems:
- Grade 1 is erythema-driven; Grade 2 requires pain. Redness alone with no pain is Grade 1, not Grade 2.
- Streak formation and a palpable cord first appear at Grade 3. A "red line tracking up the arm" is never Grade 1 or 2.
- Purulent drainage is the Grade 4 discriminator. Purulence means you have moved from managing inflammation to managing suspected infection.
- Many organizations set the escalation trigger at Grade 2 or higher (report and remove). Know your policy—but know the scale itself, because the exam tests the scale.
Do not confuse it with the VIP Score. The Visual Infusion Phlebitis (VIP) Score is a separate bedside tool (a 0–5 scale attributed to Jackson) that counts how many of pain, redness, and swelling are present; some organizations adopt it instead. When a question names the INS Phlebitis Scale, answer from the 0–4 table above.
Post-infusion phlebitis
Phlebitis can appear after the catheter is out. The 9th edition of the Infusion Therapy Standards of Practice widened the recognized post-infusion window from within 48 hours to 48–96 hours after removal, with reported rates spanning roughly 1%–23%. Practical consequence: teach patients to report new redness, pain, or a cord at a discontinued IV site for several days after removal, and never assume a site is "safe" the moment the catheter comes out.
Assessment technique:
- Inspect and gently palpate the site through a transparent dressing when possible without disrupting integrity unnecessarily.
- Compare to opposite limb when helpful.
- Ask about pain during infusion (chemical phlebitis often hurts more when the drug is running).
- Note when signs started relative to a new medication, rate change, or dressing failure.
- Document grade/findings, catheter type/gauge/site, infusates, and actions.
Exam trap: Continuing a vesicant or known irritant through a painful, erythematous peripheral site “because blood return is still present.” Blood return does not make an inflamed vein safe.
Risk factors to cluster for exam stems
- Gauge and length: larger diameters increase mechanical risk relative to vein size
- Site: hands/wrists and antecubital continuous infusions; areas of dermatitis or prior phlebitis
- Therapy: antibiotics with high irritation potential, chemo irritants, hyperosmolar solutions, vasoactive drugs
- Duration: longer dwell without reassessment
- Technique: traumatic starts, poor asepsis, inadequate securement
- Host: fragile veins, older adults, women (epidemiologic associations in some studies), immunosuppression for infectious progression
Prevention strategies that actually work
- Match device to therapy. Short peripheral for short, non-irritant therapy; consider midline or central access when osmolarity, pH, duration, or vesicant status demand it.
- Vein and site selection. Prefer straight, soft veins away from joints for continuous infusions; use visualization tools when appropriate to reduce attempts.
- Smallest effective gauge. Do not default to large-bore catheters “just in case” for routine fluids.
- Aseptic insertion and maintenance. Full skin prep dry time; protect key parts; disinfect hubs.
- Securement and dressing. Prevent motion and keep the site clean/dry/intact; replace dressings per policy or sooner if compromised.
- Drug administration practices. Correct dilution, rate, filters when required, and compatibility; use central route when indicated by drug references/INS standards of practice principles.
- Routine monitoring. At least each shift and with every access for inpatients (follow policy); teach outpatients to report pain, redness, swelling immediately.
- Timely removal. Remove at first clear signs of phlebitis meeting removal criteria, and whenever the device is unnecessary.
Management algorithm
When phlebitis is identified:
- Stop the infusion through the affected catheter.
- Assess severity and look for infectious features (purulence, fever, rapid progression, severe pain).
- Remove the catheter when indicated by grade, pain, therapy type, or infection concern—do not “wait and see” through progressive VIP findings.
- If ongoing IV therapy is required, restart in the opposite extremity when possible, using a new catheter and fresh site; escalate device type if chemical risk is high.
- Comfort measures: elevation of the limb if helpful; warm compress is often used for chemical/mechanical phlebitis after removal when not contraindicated—follow protocol. Avoid aggressive massage of a suspected infected or thrombosed cord.
- Notify the provider for moderate–severe findings, suspected infection, or if vesicant/irritant extravasation is also possible (remember infiltration/extravasation is a related but distinct complication covered elsewhere).
- Culture and antibiotics when infection is suspected—especially with purulence or systemic signs; consider blood cultures if BSI is possible.
- Document thoroughly for continuity and quality tracking (phlebitis rates are a common quality indicator).
Do not routinely irrigate a purulent peripheral site catheter as treatment, force flush against resistance, or leave an unnecessary central line in place while chasing peripheral phlebitis problems that signal overall access-planning failure.
Differentiating related complications
- Infiltration: non-vesicant fluid into tissue—cool swelling, blanching; not primarily venous inflammation
- Extravasation: vesicant into tissue—can devastate tissue; emergency protocols apply
- Thrombophlebitis: inflammation with thrombus; palpable cord may be present
- Cellulitis / exit-site infection: soft-tissue infection around the site; may coexist with phlebitis
- CRBSI: systemic infection sourced to catheter—may occur with or without dramatic local signs
Exam items may mix these; anchor on local venous inflammatory signs along the vessel path for phlebitis grading.
Quality improvement angle
Units track peripheral phlebitis rates, often per 1,000 catheter days. Spikes prompt review of securement products, irritant administration practices, dwell-time policies, and competency. For the individual CRNI nurse, the “QI move” at the bedside is simple: prevent the preventable mechanical and chemical insults, treat early grades decisively, and never normalize a painful red cord.
High-yield exam traps
- Attributing all redness to tape allergy without assessing the vein path
- Continuing infusions through progressive phlebitis because the pump is not alarming
- Using a large-gauge AC site for multi-day antibiotic irritants instead of planning appropriate access
- Managing suspected infectious phlebitis with warm compress only and no removal/escalation
- Confusing phlebitis prevention with CLABSI bundles—overlap exists (asepsis), but mechanical/chemical planning is uniquely central to peripheral phlebitis
Integrate phlebitis knowledge with Section 3.1 strategies and Section 3.3 infection response: same aseptic foundation, different clinical grading and device decisions. That integration is exactly what Domain 1B expects.
A patient receiving peripheral IV vancomycin reports burning along the vein; the site shows erythema without purulence or fever. Which mechanism is most likely primary?
Which practice best reduces mechanical phlebitis risk for a continuous peripheral infusion?
Using visual infusion phlebitis grading principles, which finding most strongly suggests need for catheter removal and escalation for possible infection rather than observation alone?
After removing a short peripheral catheter for moderate chemical phlebitis, therapy must continue. What is the most appropriate next access plan?
A peripheral IV site shows erythema and edema, the patient reports pain at the site, and a firm palpable cord with a visible red streak extends about 3 inches up the forearm. There is no drainage. What is the INS Phlebitis Scale grade?
A nurse discharges a patient two days after a short peripheral catheter was removed. The patient calls reporting new redness and a tender cord at the old site. How should this be interpreted under the 9th edition Infusion Therapy Standards of Practice?